Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y

PHYSIOLOGY & BEHAVIOR

卷:107

Article

Bowers, Mallory E.¹  Choi, Dennis C.¹  Ressler, Kerry J.^1,2 

[1] Emory Univ, Ctr Behav Neurosci, Dept Psychiat & Behav Sci, Atlanta, GA 30329 USA

[2] Emory Univ, Howard Hughes Med Inst, Atlanta, GA 30329 USA

关键词: CCK;    Cannabinoid;    NPY;    Opioid;    Enkephalin;    Endorphin;    Nociceptin;    MOR;    Extinction;    Phobia;    Panic;    PTSD;    Amygdala;   

DOI  :  10.1016/j.physbeh.2012.03.004

来源: Elsevier

【 摘 要 】

The neural circuitry of fear likely underlies anxiety and fear-related disorders such as specific and social phobia, panic disorder, and posttraumatic stress disorder. The primary pharmacological treatments currently utilized for these disorders include benzodiazepines, which act on the GABAergic receptor system, and antidepressants, which modulate the monamine systems. However, recent work on the regulation of fear neural circuitry suggests that specific neuropeptide modulation of this system is of critical importance. Recent reviews have examined the roles of the hypothalamic-pituitary-adrenal axis neuropeptides as well as the roles of neurotrophic factors in regulating fear. The present review, instead, will focus on three neuropeptide systems which have received less attention in recent years but which are clearly involved in regulating fear and its extinction. The endogenous opioid system, particularly activating the mu opioid receptors, has been demonstrated to regulate fear expression and extinction, possibly through functioning as an error signal within the ventrolateral periaqueductal gray to mark unreinforced conditioned stimuli. The cholecystokinin (CCK) system initially led to much excitement through its potential role in panic disorder. More recent work in the CCK neuropeptide pathway suggests that it may act in concordance with the endogenous cannabinoid system in the modulation of fear inhibition and extinction. Finally, older as well as very recent data suggests that neuropeptide Y (NPY) may play a very interesting role in counteracting stress effects, enhancing extinction, and enhancing resilience in fear and stress preclinical models. Future work in understanding the mechanisms of neuropeptide functioning, particularly within well-known behavioral circuits, are likely to provide fascinating new clues into the understanding of fear behavior as well 8 suggesting novel therapeutics for treating disorders of anxiety and fear dysregulation. (C) 2012 Elsevier Inc. All rights reserved.

【 授权许可】

Free